Ashkenazi Jewish Genetic Panel (AJGP)

References

Citations

  1. Khoury MJ, et al. (2003). Population screening in the age of genomic medicine. New England Journal of Medicine, 348(1): 50–58.

  2. American College of Obstetricians and Gynecologists and American College of Medical Genetics (2001). Preconception and Prenatal Carrier Screening for Cystic Fibrosis: Clinical and Laboratory Guidelines. Washington, DC: American College of Obstetricians and Gynecologists.

  3. Gilbert F (1998). Establishing criteria for a carrier detection panel: Lessons for the Ashkenazi Jewish model. Genetic Testing, 2(4): 301–304.


Go to previous sectionGo to previous sectionGo to top of pageGo to top of pageGo to next sectionGo to next section

Author: Jan Nissl, RN, BS
Sydney Youngerman-Cole, RN, BSN, RNC
Last Updated: October 12, 2006
Medical Review: Renée M. Crichlow, MD - Family Medicine
Adam Husney, MD - Family Medicine
Siobhan M. Dolan, MD, MPH - Reproductive Genetics
Renee H. Martin, PhD - Medical Genetics

© 1995-2008 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.

Click here to learn about Healthwise
Click here to learn about Healthwise
Topic Contents
 What are Ashkenazi Jewish Genetic Diseases?
 What Is an Ashkenazi Jewish Genetic Panel (AJGP)?
 What Is Carrier Screening?
 Who Should Be Tested?
 What If I Am a Carrier?
 Is the Test Accurate?
 Should I Be Tested?
 Why Not Be Tested?
 Other Places To Get Help
 Related Information
Arrow PointerReferences
 Credits